North America ELISA Diagnostics Tests Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), and End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others)

No. of Pages: 100    |    Report Code: BMIRE00029814    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America ELISA Diagnostics Tests Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America ELISA Diagnostics Tests Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America ELISA Diagnostics Tests Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rising prevalence of Infectious Diseases augmenting the demand for efficient diagnostic technologies
5.2 Market Opportunities
  • 5.2.1 Recent Organic Developments in the Market Create Lucrative Opportunities
5.3 Future Trends
  • 5.3.1 Improved Penetration of Advanced diagnostic tools propelling the market growth
5.4 Impact of Drivers and Restraints

6. North America ELISA Diagnostics Tests Market Regional Analysis

6.1 North America ELISA Diagnostics Tests Market Overview
6.2 North America ELISA Diagnostics Tests Market Revenue 2020-2030 (US$ Million)
6.3 North America ELISA Diagnostics Tests Market Forecast Analysis

7. North America ELISA Diagnostics Tests Market Analysis – by Adoption

7.1 Human
  • 7.1.1 Overview
  • 7.1.2 Human: North America ELISA Diagnostics Tests Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Veterinary
  • 7.2.1 Overview
  • 7.2.2 Veterinary: North America ELISA Diagnostics Tests Market – Revenue and Forecast to 2031 (US$ Million)

8. North America ELISA Diagnostics Tests Market Analysis – by Test Type

8.1 Sandwich ELISA
  • 8.1.1 Overview
  • 8.1.2 Sandwich ELISA: North America ELISA Diagnostics Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Indirect ELISA
  • 8.2.1 Overview
  • 8.2.2 Indirect ELISA: North America ELISA Diagnostics Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Competitive ELISA
  • 8.3.1 Overview
  • 8.3.2 Competitive ELISA: North America ELISA Diagnostics Tests Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Multiple & Portable ELISA
  • 8.4.1 Overview
  • 8.4.2 Multiple & Portable ELISA: North America ELISA Diagnostics Tests Market – Revenue and Forecast to 2030 (US$ Million)

9. North America ELISA Diagnostics Tests Market Analysis – by Application

9.1 Autoimmune Diseases
  • 9.1.1 Overview
  • 9.1.2 Multiple & Portable ELISA: North America ELISA Diagnostics Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Infectious Diseases
  • 9.2.1 Overview
  • 9.2.2 Multiple & Portable ELISA: North America ELISA Diagnostics Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Cancer Diagnosis
  • 9.3.1 Overview
  • 9.3.2 Multiple & Portable ELISA: North America ELISA Diagnostics Tests Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Protein Quantification
  • 9.4.1 Overview
  • 9.4.2 Multiple & Portable ELISA: North America ELISA Diagnostics Tests Market – Revenue and Forecast to 2030 (US$ Million)

10. North America ELISA Diagnostics Tests Market – North America Analysis

10.1 North America
  • 10.1.1 North America ELISA Diagnostics Tests Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.1.1.1 North America ELISA Diagnostics Tests Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America ELISA Diagnostics Tests Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 US: North America ELISA Diagnostics Tests Market Breakdown, by Adoption
    • 10.1.1.1.2 US: North America ELISA Diagnostics Tests Market Breakdown, by Test Type
    • 10.1.1.1.3 US: North America ELISA Diagnostics Tests Market Breakdown, by Application
  • 10.1.1.2 Canada: North America ELISA Diagnostics Tests Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 Canada: North America ELISA Diagnostics Tests Market Breakdown, by Adoption
    • 10.1.1.2.2 Canada: North America ELISA Diagnostics Tests Market Breakdown, by Test Type
    • 10.1.1.2.3 Canada: North America ELISA Diagnostics Tests Market Breakdown, by Application
  • 10.1.1.3 Mexico : North America ELISA Diagnostics Tests Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 Mexico : North America ELISA Diagnostics Tests Market Breakdown, by Adoption
    • 10.1.1.3.2 Mexico : North America ELISA Diagnostics Tests Market Breakdown, by Test Type
    • 10.1.1.3.3 Mexico : North America ELISA Diagnostics Tests Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America ELISA Diagnostics Tests Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Bio-Rad Laboratories Inc.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Idexx Laboratories Inc.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 F. Hoffmann-La Roche Ltd.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Thermo Fisher Scientific Inc.
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Abbott Laboratories
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Danaher Corp.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Pictor Ltd.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 DiaSorin SpA
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Elabscience Biotechnology Inc.
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Bio-Techne Corp.
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

1. Bio-Rad Laboratories Inc.

 

2. Idexx Laboratories Inc.

3. F. Hoffmann-La Roche Ltd.

4. Thermo Fisher Scientific Inc.

5. Abbott Laboratories

6. Danaher Corp.

7. Pictor Ltd.

8. DiaSorin SpA

9. Elabscience Biotechnology Inc.

10. Bio-Techne Corp.

north-america-elisa-diagnostics-tests-market